Skip to main content
. 2016 May 27;66(647):e457–e459. doi: 10.3399/bjgp16X685537

Table 1.

Comparison of main types of monogenic diabetes with type 1 and type 2 diabetes

Feature HNF1A-/4A-MODY HNF1B-MODY GCK-MODY T1DM T2DM
Typical age at diagnosis 10–45 years 10–45 years Birth onwards 1–30 years After 25 years
Ketonaemia/diabetic ketoacidosis Very rare Very rare Would not be predicted to occur Common Rare except in ketosis-prone subtype
First-degree relative with DM Reported in 50–60% Around 50% (high rate of spontaneous mutations) Often undiagnosed or reported as IGT/GDM 2–4% Around 50%
Insulin resistance/obesity Same as non-diabetic population Same as non-diabetic population Same as non-diabetic population Same as non-diabetic population Common
Beta-cell antibodies Negative Negative Negative Positive at diagnosis in 80–90% Negative
C-peptide after 3 years from diagnosis Normal range Normal range Normal range Low or undetectable in majority High normal
First-line drug treatment Low-dose sulphonylurea Metformin if renal function allows None Insulin Metformin

DM = diabetes mellitus. GCK = glucokinase. GDM = gestational diabetes mellitus. IGT = impaired glucose tolerance. MODY = maturity-onset diabetes of the young. T1DM = type 1 mellitus. T2DM = type 2 diabetes mellitus.